BANOPHEN Trademark

Trademark Overview


On Wednesday, September 17, 2025, a trademark application was filed for BANOPHEN with the United States Patent and Trademark Office. The USPTO has given the BANOPHEN trademark a serial number of 99397254. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, February 4, 2026. This trademark is owned by The Harvard Drug Group, L.L.C.. The BANOPHEN trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamines
banophen

General Information


Serial Number99397254
Word MarkBANOPHEN
Filing DateWednesday, September 17, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, February 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2026

Trademark Statements


Goods and ServicesAntihistamines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 17, 2025
Primary Code005
First Use Anywhere DateMonday, November 30, 2009
First Use In Commerce DateMonday, November 30, 2009

Trademark Owner History


Party NameThe Harvard Drug Group, L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDublin, OH 43017

Trademark Events


Event DateEvent Description
Wednesday, September 17, 2025NEW APPLICATION ENTERED
Wednesday, September 17, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, September 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 27, 2026ASSIGNED TO EXAMINER
Friday, January 30, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 18, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords


banophen antihistamines